CME Insider Timothy Bitsberger Buys $145K of Stock
Timothy Bitsberger bought 645 shares of CME Group Inc. for $145,125 on June 25, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Timothy Bitsberger bought 645 shares of CME Group Inc. ($CME) at an average price of $225, worth about $145,125, on June 25, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $CME is up 5.2% after 1 week, up 13.5% after 1 month and up 31.2% to date (from the $223.95 close on Jun 25, 2026).
CME
CME Group Inc.
Key Points
- Timothy Bitsberger bought 645 shares of CME Group Inc. for $145,125 on June 25, 2026, at a price of $225 each.
- CME Group's stock closed at $218.58 on June 25, significantly below its 52-week high of $329.16.
- Analysts maintain a consensus rating of 'hold' on CME Group, with a mean price target of $283.6.
Get $CME trade alerts by text
We text you when insiders, Congress or big funds trade $CME. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated CME Group Inc. alert may contain errors. Disclosures
Insider Buying and Selling at CME Group Inc.
Timothy Bitsberger purchased 645 shares of CME Group Inc. (CME) on June 25, 2026, for $145,125. The shares were bought at a price of $225 each, according to the latest transaction report. This activity reflects a personal investment by Bitsberger in the company.
Other Insiders Make Similar Moves
On the same day, several other insiders also made significant purchases. Ford Harold Eugene Jr. bought 1,067 shares at $225 each, totaling about $240,075. Similarly, Tierney Robert Jr., Patrick Maloney, and Bryan Durkin each acquired 645 shares for $145,125. This coordinated buying could signal confidence in CME Group's future prospects.
CME Group Stock Performance
CME Group's shares were trading at $218.58 on June 25, which is below its 52-week high of $329.16. The stock has faced pressure recently, trading well below its 50-day moving average of $266.98. This price action may attract attention as insiders are actively buying, suggesting they see value at current levels.
Analysts Set New Price Targets
Analysts have mixed views on CME Group. On October 14, 2026, Wells Fargo maintained an Overweight rating with a target price of $315, up from $301. Morgan Stanley also maintained an Overweight rating, raising its target to $337 from $330. In contrast, Barclays and UBS have a more cautious stance, with Equal-Weight and Neutral ratings, respectively. The consensus rating remains a 'hold' with a target mean price of $283.6 based on 15 analyst opinions.
What CME Group Inc. Does
CME Group Inc. operates global markets for trading futures and options on a wide range of asset classes, including interest rates, equities, and commodities. The recent insider purchases may reflect optimism about the company's ability to navigate current market conditions.
What’s Next for CME Group
CME Group is set to report its next earnings on October 21, 2026. As a reminder, this insider transaction reflects past activity and may not represent current market conditions. Investors will be watching for further filings and updates as the earnings date approaches.
Related Filing Alerts
Source: Timothy Bitsberger's Form 4 filing on $CME (Jun 25, 2026). Find the original filing: CME Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts